Frontometaphyseal dysplasia 2 (FMD2) is a skeletal dysplasia with supraorbital hyperostosis 23 combined with undermodeling of the bones, joint contractures and some extraskeletal features. 24
It is caused by heterozygous mutations in MAP3K7, encoding the Mitogen-Activated Protein 3-25 Kinase 7. MAP3K7 is activated by TGF-β and plays an important role in osteogenesis. Less than 20 26 patients with FMD2 and MAP3K7 mutations have been described thus far. The majority of the 27 patients harbor a recurrent missense mutation, NM_003188.3: c.1454C>T [NP_003179.1: 28 p.(Pro485Leu)], which leads to a more severe phenotype than mutations in other domains. Here 29 we describe an additional patient with FMD2 caused by the recurrent c.1454C>T MAP3K7 30 mutation, identified as a de novo variant by whole-genome sequencing. The 17-year-old boy has 31 the characteristic skeletal and facial features of FMD2. However, some novel features were also 32 observed, including growth retardation and spina bifida occulta. In line with other patients 33 harboring the same mutation he also showed keloid scars and had no intellectual disability. This 
INTRODUCTION 41
Skeletal dysplasias constitute a large and heterogeneous group of disorders characterized by a 42 broad phenotypic and genetic variability (Bonafe et al., 2015) . Short stature is the main hallmark 43 but many other features, including deformities and extra-skeletal manifestations, may also be 44 present. Abnormalities in signaling pathways crucial for the growth plate, i.e. Notch, WNT, FGF, 45
Hedgehog, and BMP pathways, are common causes of skeletal dysplasias (Geister and Camper, 46 2015) . 47
Recently, heterozygous disease-causing mutations in MAP3K7, encoding the Mitogen-Activated 48 Protein Kinase 7 (also known as TAK1), were described in Frontometaphyseal dysplasia 2 (FMD2) 49 in less than 20 patients (Wade et al., 2016; Wade et al., 2017) . This kinase is stimulated by TGF-β 50 and BMPs and plays an important role in the NF-κB signaling and is consequently a key regulator 51 of osteogenesis (Thouverey and Caverzasio, 2012) . 52
Phenotypically, patients with FMD2 are very similar to patients with frontometaphyseal dysplasia 53 1 (FMD1), caused instead by mutations in FLNA (Robertson et al., 2003) . The shared clinical 54 characteristics include sclerosis of the skull and long bones, prominent supraorbital ridges and 55 abnormal fingers. Some patients also present with extra-skeletal manifestations, such as hearing 56 loss, urogenital problems and joint contractures (Wade et al., 2016) . In addition, patients with 57 FMD2 also seem to have a predisposition to keloid scars, especially if they are females (Wade et 58 al., 2017) . 59
In some aspects, patients with FMD2 also resemble patients with cardiospondylocarpofacial 60 syndrome, which is also caused by MAP3K7 mutations (Le Goff et al., 2016) . However, this M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
Costantini A, Wallgren-Pettersson C, Mäkitie O. MAP3K7 and frontometaphyseal dysplasia 2 4 syndrome is characterized by distinct phenotypic features such as growth retardation, 62 brachydactyly, short limbs and joint laxity (Le Goff et al., 2016) . 63
Here we describe a 17-year-old male with FMD2 caused by the recurrent missense mutation 
Clinical manifestations 68
The index patient and his healthy parents were recruited at the Folkhälsan Department of 69
Medical Genetics to a research project exploring genetic causes of skeletal dysplasia. The study 70 protocol was approved by the Research Ethics Board at Helsinki University Hospital and informed 71 consents were obtained from the participants prior to the study. 72
The patient, a boy born to non-consanguineous Finnish parents, presented at birth with tetralogy 73 of Fallot, a clavicular fracture, ulnar deviation of the wrists, contractures of the elbows, pes 74 metatarsovarus, and hydronephrosis due to ureteral reflux (Table 1 ). The skull was somewhat 75 dolichocephalic with a sloping forehead, the fontanelle was large, and vertebrae C3 and C4 had 76 reduced height. The fingers and toes were long, with broad distal phalanges of the fingers. His 77 birth weight, length and head circumference (3680g / 51cm / 35.5 cm) were normal, and he 78 received 9 Apgar points. At 6 years, the boy was found to have a craniocervical malformation (a sharp angle between the 90 clivus and the dens, and caudal displacement of the conus) in combination with Chiari I-91 malformation. He underwent occipito-cervical fusion to stabilize his neck ( Fig. 1 ). Decompression 92 of the foramen magnum was performed during the same operation because of the Chiari I 93 malformation. He was found to have spina bifida occulta in several vertebrae and bilateral 94 Sprengel deformities. The Halo bracing, used for stabilization, caused severe keloid formation in 95 his back ( Fig. 1D ). He also underwent surgery for unilateral cryptorchidism. His orbital ridges were 96 increasingly prominent ( Fig. 1A-B ) and a corrective surgery was performed at 11 years to flatten 97 the protruding bony parts of the forehead. 98
The patient had always been sensitive to light but initial examinations revealed no etiology. At 99 the age of 6, he was found to have subepithelial corneal scarring (leucoma corneae), astigmatism, 100 and amblyopia. At 7 years, he had short stature (-1.5 SD) (Supplemental Fig. S1 ), scoliosis (Fig. 1C) , slightly weak 102 voice, and mild atopy, and was prone to infections. Intellectual development and school 103 performance were normal. 104
His growth, which decelerated already starting from 3-4 years of age when scoliosis was not 105 present, has progressed slowly despite normal pubertal development (Supplemental Fig. S1 ). By 106 age 17 years, his scoliosis has significantly progressed (Cobb's angle 42°) and may partly explain 107 the lack of pubertal growth spurt and his severe height deficit (148 cm; -4.3 SDS). He has flexion 108 contractures in the knees, hips and elbows and his feet are deformed and rigid. 109
Genetic findings 110
In order to identify the genetic cause in our index patient, we performed whole-genome 111 sequencing (WGS) on the trio. Pair-end sequencing (2x150 bp) was performed at the SciLifeLab 112 (Stockholm) on the HiSeqX instrument (Illumina), with an average coverage of 30X. Read 113 alignment to the human genome assembly (GRCh37) was performed with the Burrow-Wheeler 114 Aligner (BWA); data processing and variant calling were carried out using Genome Analysis Toolkit 115 (GATK). Variants were annotated using Variant Effect Predictor (VEP) and data analysed using 116 GEMINI. Candidate gene variants were filtered using a MAF < 0.001 in GnomAD and SweGen 117 databases and assuming autosomal recessive/compound heterozygous inheritance pattern or a 118 de novo variant (Ameur et al., 2017) . Furthermore, we chose the impact severity of the variant to 119 be different than "low" in GEMINI. Findings were validated by Sanger sequencing. encoding the UDP-Glucose Glycoprotein Glucosyltransferase 1. UGGT1 is involved in the quality 125 control of protein folding in the endoplasmic reticulum (Arnold et al., 2000) . However, mutations 126 in this gene have not been associated with any disease yet. On the other hand, mutations in 127 MAP3K7 have been described in two skeletal diseases: FMD2 and cardiospondylocarpofacial 128 syndrome. Based on previous studies and phenotypic correlations, the variant in MAP3K7 was 129 regarded as the cause of our patient's disorder, confirming a diagnosis of FMD2. This finding, 130 which was also validated with Sanger sequencing (Supplemental Fig. S2B-S2D Fig. 1) (Basart et al., 2015; Morava et al., 2003; Wade et al., 2016; Wade 139 et al., 2017) . Radiologically, he had a craniocervical malformation, Chiari I-malformation as well as 140 progressive scoliosis requiring surgery, and dislocated and abnormally shaped radial heads. 141
He did not have valgus but varus deformity of the feet and he had normal intellect. Moreover, he 142 had some features not previously noted in patients with the same mutation: significant growth and it might be a coincidental finding in our patient. Furthermore, Chiari I malformation, Sprengel 147 deformity and single palmar creases are similar to contractures and skeletal deformities 148 described in other individuals with FMD (Basart et al., 2015; Robertson et al., 2003; Wade et al., 149 2016; Wade et al., 2017) . In line with this, spina bifida occulta is part of the cervical spine 150 dysraphism in FMD but it has never been reported hitherto in patients with MAP3K7 mutations. 151
Finally, leucoma corneae and astigmatism were observed previously in one patient with a 152 MAP3K7 mutation (Basart et al., 2015) , suggesting that this feature may be a part of the 153 phenotypic spectrum of FMD2. 154
The majority of the patients hitherto reported as having FMD2 harbor the same recurrent 155 mutation as the one identified in our patient, c. 1454C>T [p.(Pro485Leu) ]. This mutation affects 156 the TAB2 domain of the protein (Table 1 ; Supplemental Fig.S3 ) (Wade et al., 2016; Wade et al., 157 2017) . Only 3 patients have been described as having other missense mutations (Wade et al., 158 2016; Wade et al., 2017) . These mutations cluster closer to the N-terminal, in the tyrosine kinase 159 domain, and give rise to milder phenotypes than the ones caused by the recurrent mutation 160 (Table 1 ; Supplemental Fig.S3 ). Although the majority of features in our patient overlap with the 161 ones previously described in other FMD2 patients, his phenotype also includes some novel 162 features (Table 1) . For example, short stature has not been previously reported in FMD2. 163
However, short stature is one of the hallmarks of patients with cardiospondylocarpofacial 164 syndrome, which is also caused by MAP3K7 mutations (Le Goff et al., 2016) . Furthermore, our 165 patient has additional hand and foot deformities as well as spina bifida occulta, vision problems, 166 undescended testis and hemangiomas that have not previously been described in other patients 167 with FMD2. In summary, our detailed report corroborates many of the clinical features previously described 169 in patients with FMD2 caused by the recurrent MAP3K7 mutation c. 1454C>T [p.(Pro485Leu) ] but 170 also describes some novel or unusual characteristics, in particular growth retardation, which may 171 suggest a partial overlap between FMD2 and cardiospondylocarpofacial syndrome. 
